Mitophagy: An Emerging Role in Aging and Age-Associated Diseases.
Chen G, Kroemer G, Kepp O. · 2020
Read Mitophagy: An Emerging Role in Aging and Age-Associated Diseases. by Chen G, Kroemer G, Kepp O. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7113588.txt.
Introduction
Chen, Kroemer, and Kepp review mitophagy, the process that removes worn-out mitochondria, and its role in ageing, in Frontiers in Cell and Developmental Biology. Faulty mitochondria are a hallmark of ageing: they make less energy, leak reactive oxygen, and gather DNA mutations. Mitophagy clears damaged units and restores balance under stress.
The process appears weakened in many human diseases, including brain degeneration, heart and vessel disease, and cancer, as well as in ageing itself. The authors sum up the mechanisms that control mitophagy and where it fails. Treatments that switch mitophagy back on might ease these dysfunctions, they argue, making the pathway a target worth pursuing.
Catalog record
| CREATOR | Chen G, Kroemer G, Kepp O. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mitophagy: An Emerging Role in Aging and Age-Associated Diseases By Guo Chen, Guido Kroemer, Oliver Kepp Published in: Frontiers in Cell and Developmental Biology DOI: 10.3389/fcell.2020.00200 ABSTRACT Abstract Mitochondrial dysfunction constitutes one of the hallmarks of aging and is characterized by irregular mitochondrial morphology, insufficient ATP production, accumulation of mitochondrial DNA (mtDNA) mutations, increased production of mitochondrial reactive oxygen species (ROS) and the consequent oxidative damage to nucleic acids, proteins and lipids. Mitophagy, a mitochondrial quality control mechanism enabling the degradation of damaged and superfluous mitochondria, prevents such detrimental effects and reinstates cellular homeostasis in response to stress. To date, there is increasing evidence that mitophagy is significantly impaired in several human pathologies including aging and age-related diseases such as neurodegenerative disorders, cardiovascular pathologies and cancer. Therapeutic interventions aiming at the induction of mitophagy may have the potency to ameliorate these dysfunctions. In this review, we summarize recent findings on mechanisms controlling mitophagy and its role in aging and the development of human pathologies. Keywords: mitophagy, aging, mitochondria, caloric restriction, ROS INTRODUCTION Mitochondria are highly organized and dynamic organelles that undergo continuous fission and fusion (Chen and Chan, 2009; Pham et al., 2012). They originated from endosymbiotic proteobacteria and conferred substantial advantages for eukaryotic cells during evolution. Thus, mitochondria play a critical role in ATP synthesis via oxidative phosphorylation (OXPHOS), β-oxidation regulating fatty acid metabolism, the synthesis of intermediate metabolites through the TCA cycle, as well as calcium homeostasis. On the other hand, like a double-edged sword, mitochondria can turn into a potential threat to cellular homeostasis and survival. In the past decades it has been well documented that mitochondria are the central organelle controlling apoptotic cell death and that the permeabilization of the mitochondrial outer membrane, with the resultant release of pro-apoptotic proteins such as cytochrome c, SMAC/DIABLO, ENDOG, OMI/HTR and AIF, irrevocably leads to cellular demise (Susin et al., 1999; Du et al., 2000; van Loo et al., 2002; Green and Kroemer, 2004; Liu et al., 2009; Wang and Youle, 2009; Li et al., 2017). Moreover, mitochondria are the major source of reactive oxygen species (ROS). During OXPHOS electrons originating mostly from complexes I and III of the electron transport chain, can generate ROS that in turn oxidizes proteins, lipids, and nucleic acids, inside (and outside) the mitochondria, leading to mitochondrial malfunction and cellular damage (Paradies et al., 2000; Hamilton et al., 2001; Short et al., 2005; Miyoshi et al., 2006; Zorov et al., 2014; Redza-Dutordoir and Averill-Bates, 2016). Furthermore, mitochondria serve as an origin of damage associated molecular patterns (DAMP) and in particular mitochondrial DNA (mtDNA), which, once released from mitochondria into the cytosol, can trigger inflammatory responses (Iyer et al., 2009, 2013; Tschopp, 2011; Nakahira et al., 2015; West et al., 2015; Contis et al., 2017). During aging a wide spectrum of alterations in mitochondrial structure and function can occur. Thus, although cellular antioxidants and free radical scavenging enzymes eliminate most of the generated ROS, a small proportion that escapes clearance can oxidize proteins, lipids and DNA, particularly within the mitochondria. The resulting mutational damage accumulates over lifetime, in particular affecting respiratory chain complexes, which itself results in the overproduction of ROS, forming a vicious cycle that ultimately leads to mitochondrial dysfunction (Greco et al., 2003; Petersen et al., 2003; Short et al., 2005; Lee and Wei, 2012). Morphologically, aging in flies and mammalians manifests with the enlargement of mitochondria, irregular cristae shape and size as well as a decrease in mitochondrial number (Miquel et al., 1980; Terman and Brunk, 2005; Yoon et al., 2006; Leduc-Gaudet et al., 2015). Functionally, OXPHOS activity, and thus ATP synthesis declines with age while ROS production increases in aged animals (Lee and Wei, 2012). As a result, it is not surprising that mtDNA deletions and mutations are detected in tissues from aged animals and humans (Fayet et al., 2002; Eshaghian et al., 2006; Trifunovic, 2006; Lee and Wei, 2012). Consistent with these observations, mtDNA mutator mice that express a proof-reading-deficient version of the mitochondrial DNA polymerase G (POLG) show reduced lifespan and exhibit a premature onset of aging-associated phenotypes including weight loss, reduced subcutaneous fat, alopecia (hair loss), kyphosis (curvature of the spine), osteoporosis, anemia, reduced fertility, and heart enlargement (Trifunovic et al., 2004). Macroautophagy, which is generally referred to as autophagy, is a conserved intracellular degradation mechanism that removes dangerous, unnecessary or dysfunctional cytoplasmic constituents and invading microbes (Mizushima, 2007; Schuck et al., 2014; Dou et al., 2015; Mochida et al., 2015; Chai et al., 2019). Autophagic activity declines during aging, and autophagy is required for lifespan extension by caloric restriction or caloric restriction mimetics (CRM) such as resveratrol, spermidine, and several chalcones (Eisenberg et al.; Rubinsztein et al., 2011; Lopez-Otin et al., 2016; Madeo et al., 2018; Carmona-Gutierrez et al., 2019). Although the relation between autophagy and aging has been firmly established as an important mitochondrial quality control mechanism, the role of mitophagy in aging and age-related disorders has remained elusive for a long time. However, recent studies have shown that mitophagy has a key function in delaying aging and age-related disorders such as neurodegenerative disorders, cardiovascular pathologies, and cancer. Here, we provide an update on mechanisms that control mitophagy, its role in aging and therapeutic interventions that harness mitophagy to treat age-related disorders. MOLECULAR MECHANISMS OF MITOPHAGY Mitophagy shares the core molecular machinery with general macroautophagy and can occur in an either selective or non-selective fashion (Levine and Kroemer, 2019). Thus, during nutrient starvation mitochondria were found in autophagosomes together with cytosolic proteins and organelles such as ER and peroxisomes indicative for non-selective mitophagy (Kopitz et al., 1990; Takeshige et al., 1992; Scott and Klionsky, 1998; Kim et al., 2007; Figure 1). Studies in yeast revealed that mitochondria can be selectively degraded by mitophagy, a process that involves the outer mitochondrial membrane protein SUN family protein Uth1 (Uth1), and type 2C protein phosphatase Ptc6 (Ptc6, better known as Aup1), a phosphatase localizing in the mitochondrial intermembrane space (Petros et al., 1991; Kissova et al., 2004). Mitophagy has been shown to occur under a series of potentially harmful conditions, such as oxidative stress, hypoxia, mitochondrial transmembrane potential loss, the accumulation of unfolded proteins and iron starvation. Moreover, impaired mitophagy and dysfunctional mitophagic mechanisms were associated with numerous physiological and pathological processes including development, differentiation, aging, neurodegenerative disorders, cardiovascular pathologies and cancer. [Figure: Non-selective mitophagy. Mitophagy shares the core molecular machinery with general macroautophagy and can occur in a non-selective fashion. Thus, mitochondria are engulfed during the nucleation and elongation phase into the forming phagophore together with other cellular content such as protein aggregates, endoplasmic reticulum (ER) derived structures and invasive bacteria. The fusion of the phagosome with lysosomes leads to the formation of the autophagolysosome and the degradation of its content.] PINK1 AND PARKIN-REGULATED MITOPHAGY Mutations in PTEN-induced putative kinase 1 (PINK1) and parkin RBR E3 ubiquitin protein ligase (PRKN, better known as Parkin) are associated with autosomal recessive juvenile parkinsonism characterized by motor disturbances and dopaminergic neurodegeneration. Later, genetic analysis showed the molecular mechanism which links PINK1 and Parkin in a common pathway regulating mitophagy, with PINK1 sensing mitochondrial transmembrane potential loss, followed by the recruitment of the E3 ubiquitin ligase Parkin to damaged organelles (Clark et